Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline [Yahoo!...
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
projections from 2024 to 2030 in terms of value in US$. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing. Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Biopharmaceuticals market is estimated at $412.1 billion in 2024 and is projected to grow to $698.7 billion by 2030, with a CAGR of 9.2% during the forecast period 2024-2030 Key products include monoclonal antibodies for cancer and autoimmune disorder treatments, erythropoietin (EPO) for anemia management, recombinant insulin for diabetes, G-CSF to enhance white blood cell production, interferons for viral infection treatment, and human growth hormones (HGH) for growth deficiencies. These therapies deliver solutions like gene and enzyme replacements.
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Is AbbVie a Buy, Sell, or Hold in 2026? [Yahoo! Finance]Yahoo! Finance
- Top Stock Reports for AbbVie, Coca-Cola & Chevron [Yahoo! Finance]Yahoo! Finance
- 2 Dividend Kings Quietly Beating the Market This Year [Yahoo! Finance]Yahoo! Finance
- What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders [Yahoo! Finance]Yahoo! Finance
- ????????????????????????????2035????128???????????? [CNET News]CNET News
ABBV
Earnings
- 10/31/25 - Beat
ABBV
Sec Filings
- 11/20/25 - Form F-6
- 11/4/25 - Form 10-Q
- 10/31/25 - Form 8-K
- ABBV's page on the SEC website